Matthew Pavao

Partner
Full contact info

I immensely enjoy helping companies and institutions translate ground-breaking scientific innovations into strong, creative and dynamic intellectual property assets to gain a competitive edge, maximize revenue and meet long-term business objectives.

Passions

Family

Traveling

Beer Brewing

Scuba Diving

Experience

Lexeo Therapeutics Announces $100 Million IPO

November 3, 2023

Cooley advised Lexeo Therapeutics, a clinical-stage gene therapy company advancing gene therapy candidates for genetically defined cardiovascular diseases and a genetically defined subgroup of Alzheimer’s disease, on its approximately $100 million initial public offering.

Read more

Related contacts

Eric Blanchard
Partner, New York
Peter Byrne
Partner, New York
Div Gupta
Partner, New York
Ivor Elrifi
Partner, New York
Matthew Pavao
Partner, Boston
Xander Lee
Partner, Los Angeles Santa Monica
Barbara Mirza
Partner, Los Angeles Santa Monica
Aaron Pomeroy
Partner, Colorado
Phil Mitchell
Partner, New York
Mark Ballantyne
Partner, Reston
Francis Wheeler
Partner, Colorado
Natasha Leskovsek
Of Counsel, Washington DC
Stephanie Parker Palmer
Special Counsel, Reston
Joseph Lockinger
Special Counsel, Washington DC
Christophe Beauduin
Special Counsel, New York
Randy Sabett
Special Counsel, Washington DC
Jennifer Shanley
Special Counsel, New York
Reid Hooper
Special Counsel, Washington DC
Karen Tsai
Special Counsel, Washington DC
Dayne Brown
Associate, New York
Ibe Alozie
Associate, Washington DC
Christopher Nickas
Associate, New York
DeVon Barnett
Associate, Washington DC
Carly Robinson
Associate, Reston
Calvin Lee
Associate, New York
Jayne M. Munger
Associate, New York
Megan Drill
Associate, San Diego
Erika Freeman
Associate, New York
Mor Agam
Associate, New York
Wyatt Kernell
Associate, New York
Wyatt Kernell
Associate, New York
Alexander Fullman
Associate, New York
Zimu Yang
Associate, Washington DC
Jason Minio
Paralegal Specialist, Boston
Andrew Henderson
Patent Agent, Seattle

Related Practices & Industries

Immatics Announces Collaboration With Moderna

September 11, 2023

Cooley advised Immatics, a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, on its strategic collaboration with Moderna.

Read more

Related contacts

Kenneth Krisko
Partner, Reston
Stephanie Parker Palmer
Special Counsel, Reston
J. Brian Stalter
Special Counsel, New York
Carly Robinson
Associate, Reston
David D. Suh
Associate
Freddy Yip
Associate, Hong Kong
Jacqueline Grise
Partner, Washington DC
Sharon Connaughton
Special Counsel, Washington DC
Rubin Waranch
Associate, Washington DC
Alexander Israel
Partner in Charge – Brussels, Brussels
Stella Sarma
Special Counsel, Brussels
Jan Lang
Associate, Brussels
Kimberly Nguyen
Special Counsel, Reston
Liza Hadley
Associate, Boston
Aaron Pomeroy
Partner, Colorado
Amanda Pacheco
Associate, Palo Alto
Rachel Thorn
Partner, New York
Matthew Pavao
Partner, Boston

Related Practices & Industries

Poseida Therapeutics Enters Strategic Collaboration and License Agreement With Roche

August 6, 2022

Cooley advised Poseida Therapeutics, a clinical-stage biopharmaceutical company, on its strategic collaboration and license agreement with Roche. Lawyers Ken Krisko, Marya Postner, Bin Wang, Hajra Nashin and Brendan Haberle led the Cooley team advising Poseida. 

Read more

Related contacts

Kenneth Krisko
Partner, Reston
Marya Postner
Partner, Palo Alto
Bin Wang
Special Counsel, Palo Alto
Brendan Haberle
Associate, San Diego
Edmond Lay
Associate, San Diego
Tom Coll
Partner, San Diego
Sharon Connaughton
Special Counsel, Washington DC
Jacqueline Grise
Partner, Washington DC
Amanda Pacheco
Associate, Palo Alto
Jeffrey J. Tolin
Partner, New York
Ivor Elrifi
Partner, New York
Matthew Pavao
Partner, Boston
Rachel Thorn
Partner, New York
Natasha Leskovsek
Of Counsel, Washington DC
Liza Cotter
Associate, Boston
Yasmin Roland
Associate, Brussels
David Navetta
Partner, Colorado
Patrick Van Eecke
Partner, Brussels
Maricel Mojares-Moore
Special Counsel, San Francisco

Related Practices & Industries

Reata Pharmaceuticals – $505 Million Follow-On Offering

December 9, 2019

Cooley advised the underwriters on Reata Pharmaceuticals' $505 million follow-on offering of 2,760,000 shares of Class A common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. Citigroup, Jefferies, SVB Leerink and Stifel acted as the joint book-running managers for the offering. Cantor, Baird and Ladenburg Thalmann acted as co-managers for the offering. Partners Rich Segal, Div Gupta and Charlie Kim led the Cooley team.

Read more

Related contacts

Richard Segal
Partner, New York
Div Gupta
Partner, New York
Charlie Kim
Partner, San Diego
Asher Herzog
Associate, New York
Natasha Leskovsek
Of Counsel, Washington DC
Phil Mitchell
Partner, New York
Jennifer Shanley
Special Counsel, New York
Ivor Elrifi
Partner, New York
Matthew Pavao
Partner, Boston
Kenneth Krisko
Partner, Reston
William Corcoran
Of Counsel, Boston
Stephanie Gentile
Partner, New York
Rick Jantz
Associate, Los Angeles Santa Monica
Rebecca Ross
Special Counsel, Washington DC
Francis Wheeler
Partner, Colorado

Related Practices & Industries

ERYTECH – $144 Million IPO

November 9, 2017

Cooley advised ERYTECH Pharma on its $143.7 million global offering of an aggregate of 6,180,137 ordinary shares, including the full exercise of the underwriters’ option to purchase additional shares. The global offering consisted of a US IPO of 5,389,021 American Depositary Shares, each representing one ordinary share and a concurrent private placement in Europe and other countries outside of the US and Canada of 791,116 ordinary shares.

Read more

Related contacts

Marc Recht
Partner, Boston
Brian Leaf
Partner, Reston
Div Gupta
Partner, New York
Courtney Thorne
Partner, Boston
Ivor Elrifi
Partner, New York
Matthew Pavao
Partner, Boston
Geoffrey Spolyar
Partner, Boston
Natasha Leskovsek
Of Counsel, Washington DC
Phil Mitchell
Partner, New York
Aaron Pomeroy
Partner, Colorado
Stephanie Gentile
Partner, New York
Kevin King
Partner, Washington DC
Rebecca Ross
Special Counsel, Washington DC
Francis Wheeler
Partner, Colorado
Josh Kaufman
Partner, New York

Related Practices & Industries

View more

Rankings & accolades

Chambers USA: Intellectual Property – Massachusetts (2021 – 2023)

IAM Patent 1000: Top Patent Lawyer

Super Lawyers: Leading IP Lawyer

Memberships & affiliations

Boston Patent Law Association

American Intellectual Property Law Association

Matthew provides helpful, well thought-out counsel. He is extremely practical and very creative.

Chambers USA 2021